Thyrocare Technologies Limited (Thyrocare) is a chain of diagnostic centers in India that provides services for preventative healthcare and was founded in 1996. The company has a network of over 4,000 service providers and operates across more than 2,000 cities in India.

Thyrocare has grown significantly over the years, and has become one of the largest diagnostic services providers in India, providing a wide range of pathology and radiology services. It went public in 2016.

The company's financial performance has been strong, with revenue growing consistently in recent years. The latest available revenue figures for the company are for the year ended March 31, 2021, where the company reported a revenue of INR 883.6 crore. The profit figure for the same year was INR 97.3 crore.

The major product mix for Thyrocare by revenue is preventative health check-up services. The company's services also include various pathology and radiology tests.

The major growth driver for Thyrocare in the future is expected to be the increasing demand for preventive health check-up services in India due to rising awareness about health and wellness. The growing Indian middle class and their increasing disposable incomes are also expected to drive growth.

Thyrocare operates in a highly competitive industry, with many players offering similar services. Some of the major competitors of Thyrocare include Dr. Lal PathLabs, Metropolis Healthcare, and SRL Limited.